A348150 logo

KoBioLabs, Inc Stock Price

KOSDAQ:A348150 Community·₩80.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A348150 Share Price Performance

₩0
-4830.00 (-100.00%)
₩0
-4830.00 (-100.00%)
Price ₩0

A348150 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet and slightly overvalued.

1 Risk
0 Rewards

KoBioLabs, Inc Key Details

₩69.3b

Revenue

₩18.3b

Cost of Revenue

₩51.0b

Gross Profit

₩57.4b

Other Expenses

-₩6.3b

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-325.97
73.64%
-9.14%
27.2%
View Full Analysis

About A348150

Founded
2014
Employees
n/a
CEO
Han Seung Lee
WebsiteView website
kobiolabs.com

KoBioLabs, Inc. provides microbiome therapeutics for metabolic, immune, and brain diseases. The company was founded in 2014 and is based in Seoul, South Korea.

Recent A348150 News & Updates

Analysis Article Dec 10

KoBioLabs, Inc's (KOSDAQ:348150) Shares Leap 26% Yet They're Still Not Telling The Full Story

KoBioLabs, Inc ( KOSDAQ:348150 ) shareholders would be excited to see that the share price has had a great month...

Recent updates

No updates